Covance Co-Locates Facility for Increased Patient Exposure

July 23, 2015
Applied Clinical Trials Editorial Staff

Applied Clinical Trials

LabCorp® announced that Covance Drug Development has relocated its clinical research unit in Dallas, TX, to a new, fit-for-purpose clinical research facility.

LabCorp® announced that Covance Drug Development has relocated its clinical research unit  in Dallas, TX, to a new, fit-for-purpose clinical research facility.  This unit opened earlier this month and has expanded from 72 to 100 medical beds. In addition, a LabCorp patient service center will be co-located in the CRU, at which patients will have an opportunity to learn more about volunteering and participating in early stage clinical trials.

 

Read the full release here.

Related Content:

News